Brittany Rose Bell, PA-C

Brittany Bell practices at Southern California Dermatology in San Luis Obispo, California.

Brittany Bell's NPI, 1972047587, was assigned on December 15, 2016. Brittany Bell holds California license 54069.

Brittany Bell's primary practice is Southern California Dermatology, at 805 Aerovista Pl, San Luis Obispo, CA 93401 in San Luis Obispo County. The practice phone is (949) 644-0101.

Brittany Bell's primary practice is Southern California Dermatology in San Luis Obispo, California. Brittany Bell is also affiliated with Dignity Health - French Hospital Medical Center. The medical group on file is Greater Modesto Medical Surgical Associates. Dmand AI also links Brittany Bell to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Brittany Bell practices, 4 sites in all. Vendor and product names are available with a free account.

Physician assistant is Brittany Bell's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Brittany Bell is licensed in California.

CMS counts 1,516 Medicare patients who saw Brittany Bell in 2024. The largest group is 65 to 74, with 729 patients. 75% of them have high cholesterol, and 62% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.83, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Brittany Bell's median patient age at 68, with 63% women.

In 2024, Brittany Bell wrote 1,386 Medicare Part D claims for 616 patients. 89% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Brittany Bell for performance year 2024, reported as part of a group. Brittany Bell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 24 general payments to Brittany Bell from 12 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $90.